These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 26160525)
1. Therapeutic benefit of melatonin in refractory central serous chorioretinopathy. Gramajo AL; Marquez GE; Torres VE; Juárez CP; Rosenstein RE; Luna JD; Eye (Lond); 2015 Aug; 29(8):1036-45. PubMed ID: 26160525 [TBL] [Abstract][Full Text] [Related]
2. A prospective pilot study of intravitreal aflibercept for the treatment of chronic central serous chorioretinopathy: the CONTAIN study. Pitcher JD; Witkin AJ; DeCroos FC; Ho AC Br J Ophthalmol; 2015 Jun; 99(6):848-52. PubMed ID: 25595177 [TBL] [Abstract][Full Text] [Related]
5. Oral Mineralocorticoid-Receptor Antagonists: Choroidal Parameters Changes Using OCT in Central Serous Chorioretinopathy. Faghihi H; Mohammadzadeh V; Nabavi A; Faghihi S; Kadivar S; Ghassemi F Ophthalmic Surg Lasers Imaging Retina; 2019 Nov; 50(11):726-733. PubMed ID: 31755972 [TBL] [Abstract][Full Text] [Related]
6. Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study. Bousquet E; Beydoun T; Zhao M; Hassan L; Offret O; Behar-Cohen F Retina; 2013; 33(10):2096-102. PubMed ID: 23719402 [TBL] [Abstract][Full Text] [Related]
7. Clinical experience with eplerenone to treat chronic central serous chorioretinopathy. Cakir B; Fischer F; Ehlken C; Bühler A; Stahl A; Schlunck G; Böhringer D; Agostini H; Lange C Graefes Arch Clin Exp Ophthalmol; 2016 Nov; 254(11):2151-2157. PubMed ID: 27145785 [TBL] [Abstract][Full Text] [Related]
8. Combined Topical Anti-inflammatory and Oral Acetazolamide in the Treatment of Central Serous Chorioretinopathy. Wuarin R; Kakkassery V; Consigli A; Roquelaure D; Papanastasiou A; Schutz JS; Thumann G; Chronopoulos A Optom Vis Sci; 2019 Jul; 96(7):500-506. PubMed ID: 31274738 [TBL] [Abstract][Full Text] [Related]
10. Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol. Breukink MB; Mohr JK; Ossewaarde-van Norel A; den Hollander AI; Keunen JE; Hoyng CB; Boon CJ Acta Ophthalmol; 2016 Mar; 94(2):187-97. PubMed ID: 26670630 [TBL] [Abstract][Full Text] [Related]
11. Predictors of Outcome During Eplerenone Therapy in Chronic Central Serous Chorioretinopathy:A Prospective, Open-Label Pilot Clinical Study. Rajesh B; Agrawal H; Peguda HK; Chhablani J Ophthalmic Surg Lasers Imaging Retina; 2018 Jul; 49(7):479-486. PubMed ID: 30021034 [TBL] [Abstract][Full Text] [Related]
12. Comparison of two mineralcorticosteroids receptor antagonists for the treatment of central serous chorioretinopathy. Pichi F; Carrai P; Ciardella A; Behar-Cohen F; Nucci P; Int Ophthalmol; 2017 Oct; 37(5):1115-1125. PubMed ID: 27757733 [TBL] [Abstract][Full Text] [Related]
13. Treatment of Chronic Central Serous Chorioretinopathy with Oral Methotrexate. Abrishami M; Mousavi M; Hosseini SM; Norouzpour A J Ocul Pharmacol Ther; 2015 Oct; 31(8):468-75. PubMed ID: 26172430 [TBL] [Abstract][Full Text] [Related]
14. Spironolactone versus observation in the treatment of acute central serous chorioretinopathy. Sun X; Shuai Y; Fang W; Li J; Ge W; Yuan S; Liu Q Br J Ophthalmol; 2018 Aug; 102(8):1060-1065. PubMed ID: 29089356 [TBL] [Abstract][Full Text] [Related]
15. Clinical factors related to visual outcome in central serous chorioretinopathy. Aggio FB; Roisman L; Melo GB; Lavinsky D; Cardillo JA; Farah ME Retina; 2010; 30(7):1128-34. PubMed ID: 20616688 [TBL] [Abstract][Full Text] [Related]